- Galapagos transfers predictive drug discovery databases to EMBL's European Bioinformatics Institute 23 Jul 2008 06:16 GMT
... Galapagos transfers predictive drug discovery databases to EMBL's European ... of pre-clinical candidates. BioFocus DPI also provides adenoviral reagents for rapid identification and validation of ...
- US NIAID not to go ahead with HIV vaccine trial 23 Jul 2008 02:51 GMT
... the men were to be circumcised and not to have pre-existing neutralising antibodies to adenovirus type 5 (Ad5), the common cold virus used in the vaccine as a carrier ...
- NIAID Will Not Move Forward With HIV Vaccine Trial 22 Jul 2008 21:31 GMT
... would have evaluated 2,400 U.S.-based, circumcised, gay men who lack pre-existing neutralizing antibodies to adenovirus type 5, the common cold virus used as a carrier for the HIV genes ...
- New Vaccine May Protect Against All Four Strains Of Dengue Virus 22 Jul 2008 14:53 GMT
... genes and proteins from all four dengue virus types as well as incorporating an adenovirus agent. Following intramuscular vaccination, rhesus macaques showed high antibody levels that neutralized all four ...
- GeoVax Partners with Vivalis for Use of Its Revolutionary EBx Technology to Manufacture Its MVA HIV/AIDS Vaccine 22 Jul 2008 12:55 GMT
... (MVA) than the Merck vaccine and the NIH Vaccine Research Center vaccines, which use adenovirus5 (Ad5) vectors. The Merck vaccine was withdrawn from trials in September 2007 because of ...
- --> NIH extends agreement with Galapagos 22 Jul 2008 06:36 GMT
... MECHELEN, BELGIUM--(Marketwire - July 22, 2008) - Mechelen, Belgium; ... of pre-clinical candidates. BioFocus DPI also provides adenoviral reagents for rapid identification and validation of ...
- NIH extends agreement with Galapagos 22 Jul 2008 06:25 GMT
... Last update: 2:17 a.m. EDT July 22, 2008 MECHELEN, ... of pre-clinical candidates. BioFocus DPI also provides adenoviral reagents for rapid identification and validation of ...
- GeoVax Partners with Vivalis for Use of Its Revolutionary EBx(R) Technology to Manufacture Its MVA H 22 Jul 2008 05:53 GMT
... (MVA) than the Merck vaccine and the NIH Vaccine Research Center vaccines, which use adenovirus5 (Ad5) vectors. The Merck vaccine was withdrawn from trials in September 2007 because of ...
- GeoVax Partners with Vivalis for Use of Its Revolutionary EBx(R) Technology to Manufacture Its MVA HIV/AIDS Vaccine 22 Jul 2008 05:50 GMT
... (MVA) than the Merck vaccine and the NIH Vaccine Research Center vaccines, which use adenovirus5 (Ad5) vectors. The Merck vaccine was withdrawn from trials in September 2007 because of ...
- NIAID Director Fauci Cancels Planned HIV Vaccine Trial 21 Jul 2008 10:30 GMT
... that both stimulate CD4+ T cells against HIV and both contain the cold virus adenovirus-5 ( , 3/25). The VRC candidate also contained pieces of HIV strains from around ...
- Trial of new AIDS vaccine bites the dust 21 Jul 2008 06:52 GMT
... strains from around the world to spark immunity, but also used the cold virus Adenovirus-5 - his was the culprit responsible for the failure of the Merck vaccine test. ...
- NIAID will not conduct the PAVE 100 HIV vaccine study 21 Jul 2008 00:12 GMT
... to be among males who were both uncircumcised and had pre-existing neutralizing antibodies to adenovirus type 5 (Ad5), the common cold virus used in the vaccine as a carrier ...
- News From The Journal Of Clinical Investigation: July 17, 2008 20 Jul 2008 09:26 GMT
... for the development of therapeutics for genetic and acquired heart diseases. TITLE: Coxsackievirus and adenovirus receptor (CAR) mediates atrioventricular-node function and connexin 45 localization in the murine heart AUTHOR ...
- Researchers Drop Large-Scale Trial of AIDS vaccine 20 Jul 2008 01:55 GMT
... responses to the vaccine virus and those who were not circumcised. The vaccine used adenovirus, which is a common virus, to carry parts of the AIDS virus. According to ...
- HIV Vaccine Trial Cancelled By NIH 20 Jul 2008 01:16 GMT
... to be among males who were both uncircumcised and had pre-existing neutralizing antibodies to adenovirus type 5 (Ad5), the common cold virus used in the vaccine as a carrier ...
- U.S. drops trial of one AIDS vaccine 19 Jul 2008 23:26 GMT
... and who were not circumcised. The vaccine used a common virus known as an adenovirus to carry bits of the AIDS virus. "It didn't work, it wasn't beneficial and ...
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>> | |
|
washingtonpost.com:
cbsnews.com:
bbc.co.uk:
canada.com:
abcnews.go.com:
healthday.com:
